期刊文献+

Understanding the standard of care in the treatment of type 2 diabetes in China: results from a national survey 被引量:2

Understanding the standard of care in the treatment of type 2 diabetes in China: results from a national survey
原文传递
导出
摘要 Background Given the pace with which standards of care have changed, timely assessment of their impact on routine clinical practice and patient outcomes is needed. In coordination with the Chinese Diabetes Society (CDS), we developed a quantitative survey to explore the implementation of standards of care for type 2 diabetes (T2D) in China. Methods A national online survey of physicians involved in the management of T2D in China was conducted over a 4-week period in 2012. Completed responses were obtained from 1 028 physicians. Participants responded to 52 questions designed to capture information relating to their demographic and clinical practice profiles. The questionnaire was divided into three sections: basic information, diagnosis practices and screening methods on main complications, and treatment and control practices. The questionnaire was developed in conjunction with the CDS. Results Overall, 83% of surveyed physicians were at least "aware" of the CDS guidelines on standards of care for T2D. Level of awareness was directly related to hospital grade, specialty, geographic location, professional rank and participation in CDS training. The 2-hour oral glucose tolerance test was reported as the most ever-used approach across all three hospital grades and physician specialties, with a usage rate of 97%. Respondents selected their choice of primary treatment for newly diagnosed T2D patients. Just over half (52%) indicated the use of oral anti-diabetic drugs (OAD) monotherapy, in line with CDS recommendations. However, OAD use varied considerably between different regions and city tiers. Despite hemoglobin Alc being defined as the gold standard for glucose control, it was not universally measured, with more physicians indicating routine use of glucose before fasting and glucose non-fasting. Conclusion The standards-of-care analysis has provided important insights into the current management of T2D among physicians in China across different geographical regions, hospital grades, specialties, professional statuses, and levels of CDS guideline awareness and training. Background Given the pace with which standards of care have changed, timely assessment of their impact on routine clinical practice and patient outcomes is needed. In coordination with the Chinese Diabetes Society (CDS), we developed a quantitative survey to explore the implementation of standards of care for type 2 diabetes (T2D) in China. Methods A national online survey of physicians involved in the management of T2D in China was conducted over a 4-week period in 2012. Completed responses were obtained from 1 028 physicians. Participants responded to 52 questions designed to capture information relating to their demographic and clinical practice profiles. The questionnaire was divided into three sections: basic information, diagnosis practices and screening methods on main complications, and treatment and control practices. The questionnaire was developed in conjunction with the CDS. Results Overall, 83% of surveyed physicians were at least "aware" of the CDS guidelines on standards of care for T2D. Level of awareness was directly related to hospital grade, specialty, geographic location, professional rank and participation in CDS training. The 2-hour oral glucose tolerance test was reported as the most ever-used approach across all three hospital grades and physician specialties, with a usage rate of 97%. Respondents selected their choice of primary treatment for newly diagnosed T2D patients. Just over half (52%) indicated the use of oral anti-diabetic drugs (OAD) monotherapy, in line with CDS recommendations. However, OAD use varied considerably between different regions and city tiers. Despite hemoglobin Alc being defined as the gold standard for glucose control, it was not universally measured, with more physicians indicating routine use of glucose before fasting and glucose non-fasting. Conclusion The standards-of-care analysis has provided important insights into the current management of T2D among physicians in China across different geographical regions, hospital grades, specialties, professional statuses, and levels of CDS guideline awareness and training.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第20期3524-3529,共6页 中华医学杂志(英文版)
关键词 type 2 diabetes TREATMENT GUIDELINE national survey type 2 diabetes treatment guideline national survey
  • 相关文献

参考文献18

  • 1UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet 1998; 352:837-853.
  • 2UK Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38. BMJ 1998; 317:703-713.
  • 3Holman RR,Paul SK,Bethel MA,Matthews DR,Neil HA.10-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Med 2008; 359:1577-1589.
  • 4Duckworth W,Abraira C,Moritz T,Reda D,Emanuele N,Reaven PD,et al,VADT Investigators.Glucose control and vascular complications in veterans with type 2 diabetes.N Engl J Med 2009; 360:129-139.
  • 5Gaede P,Lund-Andersen H,Parving HH,Pedersen O.Effect of a multifactorial intervention on mortality in type 2 diabetes.N Engl J Med 2008; 358:580-591.
  • 6Anderson RT,Narayan KM,Feeney P,Goff D Jr,Ali MK,Simmons DL,et al.Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators.Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes:ACCORD trial.Diabetes Care 2011; 34:807-812.
  • 7ADVANCE Collaborative Group,Patel A,MacMahon S,Chalmers J,Neal B,Billot L,Woodward M,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med 2008; 358:2560-2572.
  • 8Gregg EW,Li Y,Wang J,Burrows NR,Ali MK,Rolka D,et al.Changes in diabetes-related complications in the United States,1990-2010.N Engl J Med 2014; 370:1514-1523.
  • 9American Diabetes Association.Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 Suppl 1:S11-S66.
  • 10American Diabetes Association.Standards of medical care in diabetes-2014. Diabetes Care 2014; 37 Suppl 1:S14-S80.

同被引文献7

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部